China Resources Pharmaceutical Group Ltd.
3320
Rang în acțiuni
#4275
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Preț acțiune
$0.58910029
Ultima sincronizare: 2026-10-16
Capitalizare de piață
$3.70B
Schimbare (1 zi)
-2.23%
Schimbare (1 an)
-3.41%
Țară
HK
Tranzacționează China Resources Pharmaceutical Group Ltd. (3320)
Categorie
Healthcare
Marja operațională pentru China Resources Pharmaceutical Group Ltd. (3320)
Marja operațională la October 2026 TTM: 4.21%
Conform celor mai recente rapoarte financiare și prețului acțiunilor China Resources Pharmaceutical Group Ltd., marja operațională curentă (TTM) este 4.21%. La finalul anului 2023, compania avea o marjă operațională de 4.31%.
Istoricul marjei operaționale pentru China Resources Pharmaceutical Group Ltd. din 2013 până în 2026
Marja operațională la sfârșitul fiecărui an
| An | Marja Operațională | Schimbă |
|---|---|---|
| 2026 (TTM) | 4.21% | -10.43% |
| 2024 | 4.70% | 9.05% |
| 2023 | 4.31% | 1.17% |
| 2022 | 4.26% | 8.95% |
| 2021 | 3.91% | -7.57% |
| 2020 | 4.23% | 7.91% |
| 2019 | 3.92% | -28.86% |
| 2018 | 5.51% | 2.42% |
| 2017 | 5.38% | 1.32% |
| 2016 | 5.31% | -1.30% |
| 2015 | 5.38% | -17.48% |
| 2014 | 6.52% | -10.44% |
| 2013 | 7.28% | 0.00% |
Marja operațională pentru companii similare sau concurente
| Companie | Marja Operațională | Diferență în marja operațională | Țara |
|---|---|---|---|
| 62.34% | -85.19% |
US
|
|
| 0.00% | - |
SE
|
|
| 0.00% | - |
FR
|
|
| 0.00% | - |
IT
|
|
| 0.77% | -99.82% |
US
|
Ce este marja operațională a unei companii?
Marja operațională este un indicator esențial pentru evaluarea profitabilității unei companii. Marjele operaționale mai mari sunt de obicei mai bune, deoarece arată că o companie poate vinde produsele sau serviciile sale la prețuri mult mai mari decât costurile de producție. Marja operațională se calculează împărțind profitul companiei la venitul său.